Ann: Antimicrobial Data Published in Peer-Reviewed Journal, page-182

If these results we're all waiting patiently for aren't as good as we're hoping, we are left with a lot of 'potential'. Not the worst position to be in, but not sure where the share price will end up. Slightly negative thought, but waiting for a bit of profit and hoping for a couple zeros added to the portfolio value is getting a bit old.

Hopefully it is just building up for a decent pop and it'll all be worth the wait. I still struggle to see why these results wouldn't be good, just a bit nervy I guess.

Still holding all my shares until we get some news. Would love to know what's being talked about beind the scenes...